You just read:

Mezzion Pharma announces that it has conducted a Type C Meeting with the FDA Regarding the TOP Line Data from the FUEL Phase 3 Clinical Trial

News provided by

Mezzion Pharma Co. Ltd.

Oct 10, 2019, 19:47 ET